Status: Recruiting
SPECTRUM
Condition:
Diabetic & Age related macular oedema
Official Title:
SPECTRUM – An observational study program to investigate the effectiveness of aflibercept 8mg used in DME and nAMD in a real-world setting
The aim of the study is to describe the early and long term (up to 2y) effectiveness of intravitreal aflibercept 8 mg in a proactive regimen in a routine clinical setting in treatment naïve or pretreated patients diagnosed with neovascular age related macular degeneration (nAMD) or diabetic macula edema (DME) in multiple countries.
[INSERT TEXT HERE]
Eligible patients attending Gloucestershire Hospitals NHS FT
